61results about How to "Long-term treatment" patented technology

A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decreasing IGF-1, and treating conditions associated with carcinoid tumors and VIPomas by administering a controlled release formulation of octreotide are provided herein.

The invention discloses a preparation method of probiotic suppository and capsules for treating female inflammation. The preparation method is characterized in that female dysbacteriosis is restored by using normal probiotic floras with a conditioning effect on female vaginal diseases in the female vagina, so that the purpose of maintaining the health of female urogenital tract is achieved. The preparation method has the characteristics that a micro-ecological treatment method without drug resistance or toxic or side effect is realized by adopting a method of treating bacteria with bacteria and maintaining the stability of female lower genital tract floras, and the preparation form is vaginal suppository which is simple in preparation, convenient to use and low in cost.

The present invention relates to the field of air purification materials, in particular to a preparation method for micro-nano silver loaded active carbon for eliminating formaldehyde for a long term under a room temperature condition. The present invention provides the preparation method for micro-nano silver loaded active carbon for eliminating formaldehyde for a long term under the room temperature condition. The preparation method comprises the following steps of active carbon washing, ammonia water impregnation modification and micro-nano silver loading. Compared with the prior art, the formaldehyde purification material provided by the present invention is prepared from the loaded micro-nano silver component by taking the active carbon washed by ultrapure water and treated by the ammonia water as a carrier; and by utilizing adsorption and reduction of the active carbon, catalytic oxidation performance of the micro-nano silver to the the formaldehyde and an enrichment conversion cooperation mechanism between the micro-nano silver and the active carbon, the micro-nano silver loaded active carbon is high in decomposition rate of catalyzing and oxidizing the formaldehyde and is stable in performance.

The invention provides a method and apparatus for treating and promoting hair growth. The method for treating and promoting hair growth includes the steps that firstly, a control unit inputs any one of a light-emitting mode, a vibration mode, and a light-emitting and vibration mode by means of any one of a light-emitting mode selecting button, a vibration mode selecting button, and a light-emitting vibration mode selecting button; secondly, when a work instruction if input via a work button, any one of the mode selected from the light-emitting mode, the vibration mode, and the light-emitting and vibration mode correspondingly enables a hair treatment unit worn on one's head to work; and thirdly, the control unit stops the work of the hair treatment unit when the treatment is completed.

An object of the present invention is to provide a treatment method and a plant of an exhaust gas in which corrosion resistance of the exhaust gas treatment plant to a sulfuric acid mist after wet type desulfurization is increased. The treatment method of an exhaust gas in the present invention, wherein sulfur oxide is removed by wet type desulfurization of the exhaust gas and a sulfuric acid mist is removed by feeding ammonia into the exhaust gas, is characterized in that an ammonia gas is mixed into the exhaust gas by feeding inorganic ammonium salt to an alkali desulfurizing agent when the desulfurizing agent is sprayed into the exhaust gas to absorb and remove the sulfur oxide in the exhaust gas.

A method for application of natural vaginal flora transplantation in treating gynecological inflammation is characterized in that feminine dysbacteriosis is recovered by means of the opsonization of normal feminine vagina probiotics florae on feminine vaginal diseases, so that the feminine urogenital tract health is maintained. The method is also characterized in that bacteria are used as an antibacterial agent, and the micro-ecology treatment method free of drug resistance and side effects is realized by maintaining the stability of feminine lower genital tract florae; the adopted preparation is a vaginal embolism which is easy to make, convenient to use and quite low in cost.

The invention relates to a tooth desensitizer as well as a preparation method and application of the tooth desensitizer. The tooth desensitizer is a powdery composite material, comprises mesoporous silica nano-particles and bioactive glass which is injected into pores of the mesoporous silica nano-particles by fusing. The preparation method of the tooth desensitizer comprises the following steps: (1), providing mesoporous silica nano-particles; (2), providing bioactive glass, wherein the bioactive glass is heated until being fused; (3), immersing the mesoporous silica nano-particles into the fused biological active glass, so that the fused biological active glass is injected into the pores of the mesoporous silica nano-particles; and (4), cooling the mesoporous silica nano-particles which are injected with the bioactive glass to form the powdery tooth desensitizer. The powdery tooth desensitizer disclosed by the invention can be mixed with water to form paste, is coated on a tooth surface with a dentin sensitivity symptom by using a brush, and can deeply seal an exposed dentinal tubule, so that external stimuli in an oral cavity is isolated to achieve effect of treating dentin sensitivity.

Compositions and methods for treatment of individuals diagnosed with a dystrophin deficiency are disclosed. In particular, inhibitors of NFκB transactivation and / or inhibitors that suppress p65 expression are used to prevent and / or reverse muscle damage in animals or humans lacking dystrophin. Such compositions and methods are useful in the treatment of individuals with muscular dystrophy.

The invention discloses an injectable double-drug-loading compound chitosan hydrogel. The compound chitosan hydrogel contains liposomes, a chitosan solution, antibiotics, hydroxyapatite and a cross-linking agent, wherein the liposomes contain lipoids and osteoporosis drugs in a mass ratio of (0.5-1.5) to (0.01-0.5), the chitosan solution consists of chitosan and acetic acid; and the hydroxyapatiteis prepared from inorganic minerals and an alkaline solution. The invention further discloses a preparation method of the injectable double-drug-loading compound chitosan hydrogel. By virtue of different cross-linking degrees of the hydrogel prepared by virtue of the method, the hydrogel can be released in different stages, is capable of resisting inflammations and treating osteoporosis for a long time and has good application prospects in the biomedical field.

The present invention relates to a method or process for the manufacture of a virus and prion save native fibrinogen concentrate of high purity and low amounts of fibrinopeptide A and fibronectin.

An adjustable annuloplasty ring assembly (10) comprises a support ring (30), an adjustable ring (32) nested at least partly within the support ring, and at least one deployable pressing element (34) for deforming the adjustable ring using the support ring (30) as support. Plural pressing elements (34) may be used at different positions around rings. Each pressing element (34) may have a variable extents of deployment, to vary the extent of deformation of the adjustable ring at the position of the pressing element. Each pressing element may comprise a deflectable blade (40), and the state of the blade may be retained by a ratchet (50). The pressing elements may be operated in a predetermined controlled sequence.

An object of the present invention is to provide a treatment method and a plant of an exhaust gas in which corrosion resistance of the exhaust gas treatment plant to a sulfuric acid mist after wet type desulfurization is increased. The treatment method of an exhaust gas in the present invention, wherein sulfur oxide is removed by wet type desulfurization of the exhaust gas and a sulfuric acid mist is removed by feeding ammonia into the exhaust gas, is characterized in that an ammonia gas is mixed into the exhaust gas by feeding inorganic ammonium salt to an alkali desulfurizing agent when the desulfurizing agent is sprayed into the exhaust gas to absorb and remove the sulfur oxide in the exhaust gas.

The invention discloses a feed additive for a ewe. The feed additive comprises the following components by mass percent: 28-32% of hawthorn powder, 28-32% of eucommia bark leaf powder, 18-22% of gynostemma pentaphylla powder, 18-22% of ginkgo leaf powder and nano-zinc oxide accounting for 1-1.5% of the total addition amount of the hawthorn powder, the eucommia bark leaf powder, the gynostemma pentaphylla powder and the ginkgo leaf powder, wherein the hawthorn powder comprises hawthorn pulp powder and hawthorn kernel powder in the mass ratio of 3 to 1. According to the feed additive, the hawthorn powder, the eucommia bark leaf powder, the gynostemma pentaphylla powder and the ginkgo leaf powder are combined with a novel zinc source-the nano-zinc oxide capable of promoting nutrient absorption of the organism, and the mixture ratio is optimized by the functional complementation principle, so that the reproductive performance of the ewe can be improved. The feed additive does not contain antibiotics, is healthy and green, and is simple to prepare, lower in production cost and wider in application prospect.

Apparatus and method are disclosed for sustained delivery of a wide range of plant supplemental and treatment materials. The treatment materials are delivered to the plant in a non-aqueous gaseous phase.

The invention belongs to the field of pharmacy, and particularly relates to a compound reserpine orally disintegrating tablet for treating hypertension and a preparation method of the compound reserpine orally disintegrating tablet. The compound reserpine orally disintegrating tablet is prepared from the following raw and auxiliary materials in parts by weight: 0.03 part of reserpine, 1 part of hydralazine hydrochloride, 0.025 part of cyclopenthiazide, 1.5 parts of hydrochlorothiazide, 2 parts of promethazine hydrochloride, 30 parts of potassium chloride, 5 parts of rutin, 2.5 parts of phosphate chloroquine, 1 part of vitamin B1, 1 part of vitamin B6, 2-10 parts of a stabilizer fumaric acid and other pharmaceutical adjuvants. An experiment result shows that the orally disintegrating tablet is short in onset time, long in medicine duration time, and convenient for treatment of a patient for a long period of time; the medication safety is improved; meanwhile, the prescription is high in process stability, and is free of effects of environmental temperature and humidity; and the difference between batches of the preparations is significantly reduced; and the stability of a sample is improved.

The invention discloses a degradable implantation catheter carrying specific drug particles such as an iodine-125 brachytherapy source and sustained release drug particles such as sustained release fluorouracil particles and the like. The catheter comprises a catheter body for accommodating the drug particles and spacer blocks arranged in the catheter body and used for spacing drugs. The degradable implantation catheter carrying the drug particles can be loaded with sufficient antitumor drugs and carry the drugs to be implanted into a tumor part of a patient together, the antitumor drug particles realize predetermined distribution in the tumor, do not enter a blood vessel to be moved through flushing and can still keep predetermined distribution in fluid-containing and necrotic lacunas of a tumor body, and the implanted drug particles can follow a tumor change part correspondingly instead of being left outside a treated part when the catheter is degraded and the tumor body shrinks.

This invention relates to topical pharmaceutical preparations and methods for the treatment of acute and chronic pain and inflammation therewith. The preparations have a saturated solution of an active pharmaceutical ingredient in a solvent therefor in intimate combination and contact with a suspension of nanoparticles of the active pharmaceutical ingredient in the solvent, and a pharmaceutically acceptable carrier therefor, and are administered topically.

The invention relates to the technical field of a water treatment material, and discloses a preparation method of a constructed wetland phosphate removing substrate material. The method comprises the following steps: cleaning of freshwater mussel shells, natural drying, crushing of mussel shells into fragments, and classified screening. The phosphate removing substrate material is prepared by agricultural wastes, and has the advantages of low cost, easily available raw materials, simple processing, and resource utilization; the material can replace common phosphate removing substrates in constructed wetlands, and simulated constructed wetland tests prove that the phosphate removing substrate can remove phosphor in riverway water bodies and cultivation sewage with high efficiency.

The invention relates to a preparation method of a hydroxyapatite material doped with fluorine and potassium. The preparation method of the hydroxyapatite material doped with fluorine and potassium comprises the following steps: (1) uniformly mixing a Ca(NO3)2.4H2O aqueous solution with a H3PO4 aqueous solution to obtain a mixed solution, adjusting pH value of the mixed solution till sediment is generated, separating out the sediment and washing the sediment; (2) drying the sediment obtained by the step (1), calcining the sediment at the temperature of 1300-1500 DEG C, and then quickly cooling the sediment to prepare alpha-calcium phosphate powder; (3) dispersing the alpha-calcium phosphate powder prepared by the step (2) in an alkaline solution containing K<+> and F<->, standing and aging at 80-160 DEG C for more than 12 hours, separating out powder, and then washing and drying to prepare the hydroxyapatite material doped with fluorine and potassium. By virtue of the preparation method, the problems that potassium salt is easily dissolved in water and not easily doped in the hydroxyapatite are solved; nanocrystals of the prepared hydroxyapatite material doped with fluorine and potassium are small in grain size and high in crystal purity, so that the hydroxyapatite material doped with fluorine and potassium can be taken as a novel method with functions of treating hypersensitive dentin, desensitizing and repairing and is long-term and efficient in treatment on hypersensitive dentin.

The invention discloses a feed additive for a fattening sheep. The feed additive comprises the following components by mass percent: 28-32% of hawthorn powder, 28-32% of eucommia bark leaf powder, 18-22% of gynostemma pentaphylla powder, 18-22% of mulberry leaf powder and nano-zinc oxide accounting for 1-1.5% of the total addition amount of the hawthorn powder, the eucommia bark leaf powder, the gynostemma pentaphylla powder and the mulberry leaf powder, wherein the hawthorn powder comprises hawthorn pulp powder and hawthorn kernel powder in the mass ratio of 3 to 1. According to the feed additive, the hawthorn powder, the eucommia bark leaf powder, the gynostemma pentaphylla powder and the mulberry leaf powder are combined with the nano-zinc oxide capable of promoting nutrient absorption of the organism, and the mixture ratio is optimized by the functional complementation principle, so that the production performance of the fattening sheep is improved and the quality of sheep meat is also improved. The feed additive does not contain antibiotics, is healthy and green, and is simple to prepare, lower in production cost and wider in application prospect.

Electrical stimulation devices can be used to treat tinnitus. For example, tinnitus can be treated using implantable electrodes and stimulation devices for delivering electrical stimulation to a patient's cochlear region. Cochlear surface electrode(s), endosteal electrode(s), subendosteal electrode(s), intraosseous electrode(s), or short intracochlear electrode(s) (or a combination there-of), connected to existing or modified cochlear implant receiver / stimulator technology, can provide a successful model for long-term treatment of tinnitus in a large number of patients. In some cases, patients can simply turn on the tinnitus implant when experiencing troublesome tinnitus and gain instant relief.

The invention provides a VEGF antibody-carrying ophthalmic thermosensitive hydrogel implant and a preparation method thereof, and relates to a medical preparation and a preparation method thereof. The implant is a thermosensitive hydrogel for ophthalmic injection, and the phase change temperature of the thermosensitive hydrogel is 34DEG C-35DEG C; the thermosensitive hydrogel is selected from a thermosensitive NIPAAm hydrogel and carries a VEGF antibody; and the mass concentration of a thermosensitive hydrogel solution is 10%-20%. According to the VEGF antibody-carrying ophthalmic thermosensitive hydrogel implant, an anti-VEGF monoclonal antibody drug is slowly released, a relatively noninvasive method is used, the anti-VEGF monoclonal antibody drug and a gel are uniformly mixed to prepare a gel system which presents a liquid state in vitro and quickly changes into a semisolid state when injected into eyeballs, so the drug arrives the posterior segment through the injection mode to achieve the effect of locally slow release.

The embodiment of the invention discloses a mesenchymal stem cell biological scaffold, a preparation method and applications thereof. The method comprises the following steps: dispersing mesenchymal stem cells into a mixture of chlorinated chitosan and beta-sodium glycerophosphate to form the mesenchymal stem cell biological scaffold. According to the embodiment of the invention, chlorinated chitosan and beta-sodium glycerophosphate are used as raw materials to prepare a chitosan hydrogel with temperature sensitivity, ie., the mesenchymal stem cell biological scaffold provided by the embodiment of the invention, wherein the material has the characteristics of stable physical properties, good histocompatibility and good biodegradability, especially has the characteristic of slow solidification at 37 DEG C, is suitable for carrying mesenchymal stem cells to perform osteoarthritis articular cavity injection treatment, plays a role in slow release of cells, and plays a role in long-term treatment.

Chilblain is a common and frequent disease in late autumn, winter and early spring; a plurality of methods are provided for treating chilblain at home and abroad, but few methods have ideal effects. The invention discloses a quick-acting chilblain cream. The quick-acting chilblain cream is prepared from the following raw materials in parts by weight: 3-6 parts of chicken oil, 1-3 parts of bee wax and 1-2 parts of a heparin sodium solution. A preparation method of the quick-acting chilblain cream comprises the following steps: heating and melting the chicken oil; adding the bee wax and the heparin sodium solution when the temperature of the oil is 60-70 DEG C, stirring the materials into cream, and packing the cream into boxes. The quick-acting chilblain cream has the characteristics of being short in course of treatment, excellent in curative effect, free of toxic and side effect and safe, can be used for preventing and treating chilblain.

A method and compound for altering the status of both innate and adaptive immune pathways in both animals and humans are disclosed. The status alteration results in the immune response being primed whereby an accelerated and more robust response is generated when the animal or human is challenged by pathogens that lead to a wide range of disease states. The disclosed method utilizes a compound derived from a lipopolysaccharide (LPS) of gram-negative bacteria. The compound itself is a natural product with no observed adverse environmental impact. By priming the immune pathways according to the disclosed inventive concept, the severity of various disease states can be reduced, can be resolved more quickly, or can be avoided entirely.

The invention is directed to methods and compositions for curing migraine headaches. In particular, compositions are described involving the combination of dexamethasone, lidocaine, and thiamine. The methods of curing a patient of migraines having trigeminal or occipital neuralgia involves administering, by subcutaneous injection during a single treatment session, a combination of dexamethasone, lidocaine and thiamine to several craniofacial nerves.

The invention discloses a chilblain cream, which is prepared from the following raw materials in part by weight: 8 to 12 parts of chicken oil and 1.5 to 3 parts of beeswax. The preparation method of the chilblain cream comprises the following steps: heating and melting the chicken oil; and adding the beeswax to an oil fluid to stir to a cream when the oil temperature is between 65 DEG C and 75 DEG C; and packaging the cream into a box. The chilblain cream provided by the invention has the characteristics of short course of treatment, good curative effect, no toxic or side effect and safety, and has good curative effect on chilblains which are festered or not festered.